Medical and Health Industry Weekly (July 13 - July 17)

Joint release: Sina Medicine, Sadie consultant one-week overview: policy and regulations, the Ministry of Civil Affairs and other nine departments issued "guidance on accelerating the implementation of the elderly home aging transformation project", to guide all regions to speed up the implementation of the elderly home aging transformation project, for the elderly home for the elderly for welfare; 6 consistency evaluation acceptance number, another 14 declared production application number status update, investment and financing, domestic medical and health field a total of 12 investment and financing events, the financing amount of 924 million yuan, foreign medical health field, a total of 4 key investment and financing events, the total amount of financing is about 118 million U.S. dollars ... Medical and health industry this week inventory, wonderful continue! Policy direction this week a total of 4 policy and regulations issued, respectively, "on the implementation of the fourth batch of smart health old-age application pilot demonstration notice," "new crown pneumonia outbreak drug clinical trial management guidelines (trial)," on accelerating the implementation of the elderly home aging transformation project guidance, and "on the approval of registration of 107 medical device products announcement (2020 No. 83).
as follows: Table 1 This week issued the list of policy documents data source: relevant departments, Sadie consultants finishing key analysis: the implementation of the elderly home aging transformation project is the General Office of the State Council on the promotion of the development of elderly services (State Office issued (2019) No. 5) deployment of an important task.
to guide all regions to speed up the implementation of the elderly home aging transformation project, the Ministry of Civil Affairs and other nine departments jointly issued "on accelerating the implementation of the elderly home aging transformation project guidance", around the construction transformation, facilities, elderly supplies configuration and other aspects, the development of the elderly home aging transformation projects and elderly supplies configuration recommendation list, including ground transformation, door transformation and other 7 categories of 30 transformation projects, guide the elderly to determine the needs of the region' multi-level transformation
the new trend of drug registration declaration, this week added 55 cases of acceptance number.
from the drug category, the largest number of chemical drug registration declarations received, 46 cases, accounting for 84%;
from the type of registration declaration, 29 cases as supplementary applications, accounting for 52%, imitation acceptance accounted for 22%, new drug acceptance accounted for 9%, import and import re-registration received 2%.
from the declaration of enterprises, this week's most accepted enterprises for Guangdong East Sunshine Pharmaceutical Co., Ltd. and Anhui Shuanghe Pharmaceutical Co., Ltd., the number of accepted are 7 cases, followed by Fu'an Pharmaceutical Group Hubei People's Pharmaceutical Co., Ltd., the number of accepted cases of 3 cases, again is Jiangxi Minnanhai Xin Pharmaceutical Co., Ltd. and other 5 enterprises, the number of acceptances are 2 cases, the remaining number of enterprises are accepted 1 case.
Figure 1 This week the national acceptance of registered declaration drug category data source: Sadie consultant pharmaceutical health industry brain map 2 This week the national acceptance of drug registration declaration type data source: Sadie consultant pharmaceutical health industry brain map 3 This week the number of national enterprises declared drug registration TOP8 data source: Sadie consultant pharmaceutical health industry brain consistency evaluation, this week added 16 application numbers.
from the product point of view, mainly involved in klinmycin phosphate injection, injection of sodium ate, injection of cephalosporine, benzodiazepine chloride flat tablets and other 10 varieties.
from the application enterprises, Fu'an Pharmaceutical Group Hubei People's Pharmaceutical Co., Ltd. the largest number of applications, the number reached 3 cases.
Form 2 This week's consistency evaluation application number list data source: Sadie Consultants Pharmaceutical Health Industry Brain Reporting Production Status, a total of 14 application numbers updated this week.
from the product point of view, mainly involved in the cessibu capsules, doso-alkali injections, carbonate swiram tablets and other 13 varieties.
from the application type, 13 varieties are generic drugs.
Table 3 This week reported the production status update of the application number list data source: Sadie consultant pharmaceutical health industry brain key analysis: this week 5 new drug declaration s2 cases for PD-L1 monototrex, the application enterprise for Zhaoke (Guangzhou) Cancer Drugs Co., Ltd. and Baoship Biopharmaceutical Technology (Shanghai) Co., Ltd.
although the domestic has AstraZeneca's davali yumonoandagain and Roche's Atellizhu mono-resistance 2 PD-L1 monotonica listed, while NMPA has approved 11 clinical cases, but because of the indications are not the same, the domestic market after the competition will not be as fierce as PD-1 monotonica.
investment and financing trend to the domestic investment and financing market, this week in the field of pharmaceutical health, a total of 12 investment and financing incidents, the amount of financing of 924 million yuan.
investment target for the health medicine, Pulse medical and other enterprises, mainly involved in medical devices, medicine and other fields.
the highest amount of capital financing in terms of disclosure amounts, at $32 million.
Table 4 This week's domestic investment and financing event data source: Sadie consultant say pharmaceutical health industry brain overseas investment and financing market, this week in the field of pharmaceutical health a total of 4 key investment and financing events, the total amount of financing is about 118 million U.S. dollars, investment target Movano, Medly Pharmacy and other enterprises, mainly related to medical devices, medical services, medicine and other fields.
, Medly Pharmacy received the highest amount of $100 million in financing.
Table 5 This week's overseas investment and financing event data source: Sadie consultant saedi pharmaceutical health industry brain key analysis: At present, the world has confirmed more than 7000 rare diseases, less than 10% of the disease has approved treatment drugs or programs, and there are more than 20 million rare patients in China, but domestic listed drugs are few, and rely on imports.
in this context, focusing on the field of treatment of rare diseases, the medical sector is more concerned by investors.
Was founded in October 2019 and although it has not been established for a long time, Round A has received up to $80 million in financing.
in the future, the drug will focus on proven drugs while helping to accelerate the global development of pharmaceuticals.
.